The term Mild Cognitive Impairment, or MCI, is increasingly being used to describe a syndrome of memory impairment that does NOT significantly impact daily activities and is not accompanied by declines in overall cognitive function.

Researchers have found that between 6 and 25 percent of people with MCI progress on to Alzheimer’s, which has raised questions about whether MCI might represent some kind of "transitional stage" between normal aging and dementia.

Many experts currently believe that MCI, as well as age-related memory loss, may always be an early form of Alzheimer’s, and progression to symptomatic Alzheimer’s disease may be only a matter of time.

However, in some people, the progression may be very slow, so the person may die of other causes before displaying the full spectrum of Alzheimer’s symptoms.

MCI is recognized as a clinical condition that requires ongoing assessment and possibly treatment to delay its progression.

Research into MCI is continuing.

Vitamin E combined with Vitamin C. Vitamin E is a powerful antioxidant that should be taken by nearly all people, not just those afflicted with Alzheimer’s disease. Antioxidants help remove so-called “free radical” oxygen that is harmful to cells, especially nerve cells in the brain. It turns out that Vitamin E is more potent in the body when taken simultaneously with Vitamin C. These two vitamins have a synergistic effect